ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Contract Service Firm Avista Is Emerging

by Michael McCoy
August 3, 2015 | APPEARED IN VOLUME 93, ISSUE 31

Avista Pharma Solutions has taken another step in building a drug R&D and manufacturing service with the acquisition of Scynexis’s contract R&D assets in Research Triangle Park, N.C. Avista was formed in June when Ampersand Capital Partners acquired Array BioPharma’s chemistry, manufacturing, and control operations in Longmont, Colo. A related company, Accuratus Lab Services, operates analytical and microbial testing labs. Together, the three businesses have more than 170,000 sq ft of lab and manufacturing space. Scynexis, meanwhile, is relocating to Jersey City, N.J., to focus on developing the antifungal SCY-078.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment